Effect of subinhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to bronchial mucins collected from cystic fibrosis patients [4]

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 4, 2004, Pages 686-688

  Carfartan, Geneviève ^a   Gerardin, Patrick ^a   Turck, Dominique ^a   Husson, Marie Odile ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Mucoid strains; Non mucoid strains; Solid phase adherence assays

Indexed keywords

AZITHROMYCIN; MUCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRONCHUS MUCUS; CELL ADHESION; CONTROLLED STUDY; CORRELATION FUNCTION; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG MECHANISM; LETTER; MINIMUM INHIBITORY CONCENTRATION; MUCUS SECRETION; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA;

AZITHROMYCIN; BACTERIAL ADHESION; BRONCHOALVEOLAR LAVAGE FLUID; CYSTIC FIBROSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MUCINS; PSEUDOMONAS AERUGINOSA;

EID: 4544281523     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh133     Document Type: Letter

References (8)

1. Jaffe, A., Francis, J., Rosenthal M. et al. (1998). Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 351, 420.
2. Culic, O., Erakovic, V. & Cepelak, I. et al. (2002). Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. European Journal of Pharmacology 450, 277-89.
3. Molinari, G., Guzman, C. A., Pesce, A. et al. (1993). Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolides. Journal of Antimicrobial Chemotherapy 31, 681-8.
4. Ichimiya, T., Takeoka, K. & Hiramatsu, K. et al. (1996) The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. Chemotherapy 42, 186-91.
5. Tateda, K., Ishii, Y. & Matsumoto, T. et al. (1996). Direct evidence for Pseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. Antimicrobial Agents and Chemotherapy 40, 2271-5.
6. Vishwanath, S. & Ramphal, R. (1984). Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin. Infection and Immunity 45, 197-202.
7. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing - Eleventh Informational Supplement. NCCLS, Wayne, PA, USA.
8. Danesi, R., Lupetti, A. & Barbara, C. (2003). Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. Journal of Antimicrobial Chemotherapy 51, 939-45.